IRIS
RICCIO, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.486
EU - Europa 814
AS - Asia 766
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
OC - Oceania 1
Totale 3.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.466
IT - Italia 498
SG - Singapore 281
CN - Cina 187
HK - Hong Kong 146
VN - Vietnam 124
IE - Irlanda 74
NL - Olanda 56
FI - Finlandia 42
CI - Costa d'Avorio 39
RU - Federazione Russa 39
DE - Germania 27
CA - Canada 18
FR - Francia 14
GB - Regno Unito 14
IN - India 13
UA - Ucraina 13
SE - Svezia 10
BG - Bulgaria 9
TR - Turchia 5
JP - Giappone 4
RO - Romania 4
CH - Svizzera 3
EU - Europa 3
AT - Austria 2
IL - Israele 2
IR - Iran 2
LV - Lettonia 2
MX - Messico 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
ID - Indonesia 1
IM - Isola di Man 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
Totale 3.112
Salva come PNG Salva come JPEG
Città #
Singapore 227
Chandler 222
Hong Kong 146
Napoli 129
Ashburn 124
Dong Ket 124
Santa Clara 124
Millbury 82
Naples 69
Beijing 62
Des Moines 53
Amsterdam 50
Dublin 43
Nanjing 42
Princeton 41
Lawrence 32
Boston 28
Caserta 24
Wilmington 24
Seattle 19
Washington 19
Jacksonville 13
Hebei 12
Los Angeles 12
Ottawa 12
Milan 11
Nanchang 10
Rome 10
Sciacca 10
Duncan 9
Redwood City 9
Sofia 9
Jiaxing 8
Helsinki 7
Nuremberg 7
Fairfield 6
Boardman 5
Houston 5
New York 5
Riccione 5
Sesto San Giovanni 5
Shenyang 5
Tianjin 5
Toronto 5
Woodbridge 5
Afragola 4
Bucharest 4
Dallas 4
Falkenstein 4
Frattamaggiore 4
London 4
Marano Di Napoli 4
Norwalk 4
Augusta 3
Baar 3
Brescia 3
Changsha 3
Frankfurt am Main 3
Istanbul 3
Maddaloni 3
Menlo Park 3
Munich 3
Nardò 3
Pomezia 3
San Giorgio Ionico 3
Shanghai 3
Absecon 2
Ann Arbor 2
Baronissi 2
Casoria 2
Colorado Springs 2
Crespano Del Grappa 2
Erice 2
Formia 2
Giugliano In Campania 2
Gragnano 2
Halle 2
Hangzhou 2
Jinan 2
Las Vegas 2
Milazzo 2
Ningbo 2
Pavullo nel Frignano 2
Perugia 2
Piano Di Sorrento 2
Pisticci Scalo 2
Pune 2
Riga 2
San Mateo 2
Sant'arpino 2
Senigallia 2
Stockholm 2
Tokyo 2
Zhengzhou 2
Abano Terme 1
Abidjan 1
Altamura 1
Anshan 1
Ardabil 1
Beni Mellal 1
Totale 2.007
Salva come PNG Salva come JPEG
Nome #
Il nefrologo nel trattamento dell’iperammoniemia da disordini del ciclo dell’urea 128
Parapelvic cysts, a distinguishing feature of renal Fabry Disease. 81
Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer 80
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 66
Alterations of functional connectivity of the motor cortex in Fabry disease: An RS-fMRI study 66
Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease 66
Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients? 65
Immunosuppression and multiple primary malignancies in kidney transplanted patients. A single-institute study 64
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial 62
Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study. 61
6-tips diet: a simplified dietary approach in patients with chronic renal disease. A clinical randomized trial 61
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group 60
Current tissue molecular markers in colorectal cancer: A literature review 60
Default mode network modifications in Fabry disease: A resting-state fMRI study with structural correlations 56
Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media 55
Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis 54
Striatonigral involvement in Fabry Disease: A quantitative and volumetric Magnetic Resonance Imaging study 53
A strange epigastric pain. 52
ROLE OF HFR CARTRIDGE IN THE REMOVAL OF MEDIATORS OF INFLAMMATION IN HEMODIALYSIS PATIENTS 52
Pituitary function and morphology in Fabry disease. 52
Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial 50
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography 49
Cerebrovascular and Brain Abnormalities In Autosomal-Dominant Polycystic Kidney Disease: Role Of 3d Time-of-Flight Magnetic Resonance Angiography 48
ADPKD and metformin: from bench to bedside 46
Terapia enzimatica sostitutiva nella malattia di Fabry: cosa abbiamo imparato dallo switch? 45
Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry disease. 44
Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995–2019 44
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 43
Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival 43
Optical Coherence Tomography Angiography Findings in Fabry Disease 43
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 42
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease. 41
Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease 41
Treatment with Agalsidase Alfa during Pregnancy in a Heterozygous Female with Fabry Disease 41
Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients 41
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: A randomized trial 40
Early Biomarkers of Fabry Nephropathy: A Review of the Literature. 39
Endothelial-mediated coronary flow reserve in patients with Anderson-Fabry disease 38
Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease 38
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 38
Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease 37
Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature 35
Fabry's disease: a comparison of the effectiveness of two different enzyme replacement therapies 35
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis. 35
Does left ventricular function predict cardiac outcome in Anderson-Fabry disease? 35
Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data 34
Atrial septum aneurysm: an unusual manifestation in ADPKD? 34
Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease 34
Renal denervation in ADPKD: an exceptional case 34
Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease 34
Reduced intracranial volume in Fabry Disease: Evidence of abnormal neurodevelopment? 34
Data on the assessment of LV mechanics by speckle tracking echocardiography in ADPKD patients 33
Association between Left Atrial Deformation and Brain Involvement in Patients with Anderson-Fabry Disease at Diagnosis 31
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease 30
Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family 30
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 29
Nutritional treatment in chronic kidney disease: the concept of nephroprotection. 29
Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study 29
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 28
RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study 26
Parapelvic Cysts: An Imaging Marker of Kidney Disease Potentially Leading to the Diagnosis of Treatable Rare Genetic Disorders? A Narrative Review of the Literature 26
Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trial 26
Layer-specific longitudinal strain in Anderson–Fabry disease at diagnosis: A speckle tracking echocardiography analysis 26
Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol 26
Fanconi syndrome with lysinuric protein intolerance 25
Therapeutic advances in ADPKD: the future awaits 25
Methylome Profiling in Fabry Disease in Clinical Practice: A Proof of Concept 25
Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease. 24
Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial 24
SWITCH TO AGALSIDASE ALFA AFTER THE SHORTAGE OF AGALSIDASE BETA IN FABRY DISEASE: A SYSTEMATIC REVIEW WITH METANALYSIS OF THE LITERATURE 23
Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease 23
Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact? 22
The Retinal Vessel Density as a New Vascular Biomarker in Multisystem Involvement in Fabry Disease: An Optical Coherence Tomography Angiography Study 22
Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3-5: Are They Robust? A Fragility Index Analysis 21
The potential use of biomarkers in predicting contrast-induced acute kidney injury. 21
Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report. 21
Tolvaptan vs. somatostatin in the treatment of ADPKD: A review of the literature 20
Cardiopulmonary determinants of reduced exercise tolerance in Fabry disease 20
Assessing brain involvement in Fabry disease with deep learning and the brain‐age paradigm 19
Familial polycystic kidneys with no genetic confirmation: Are we sure it is ADPKD? 18
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 15
Microstructural damage of the cortico-striatal and thalamo-cortical fibers in Fabry disease: a diffusion MRI tractometry study 14
Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease Case Reports 14
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations 11
The Case | A patient with autosomal dominant polycystic kidney disease with an atypical kidney magnetic resonance image 9
Clinical manifestation of patients with Fabry disease and R356W GLA variant 8
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin 8
Clinical and Pathophysiologic Correlates of Basilar Artery Measurements in Fabry Disease 7
Cardiac involvement in Anderson–Fabry disease. The role of advanced echocardiography 6
Totale 3.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 0 0 0 0 4 17 34 41 32 17
2020/2021300 4 3 11 6 28 18 10 16 34 13 23 134
2021/2022450 4 0 5 4 7 11 28 18 33 52 116 172
2022/2023571 75 44 26 41 55 69 9 57 97 53 30 15
2023/2024561 23 92 41 38 35 76 6 62 15 12 118 43
2024/2025765 125 97 23 54 53 187 226 0 0 0 0 0
Totale 3.343